English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/60708
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Common features at the start of the neurodegeneration cascade

AuthorsHervás, Rubén ; Oroz, Javier ; Galera-Prat, Albert ; Goñi Ramos, Óscar ; Valbuena, Alejandro ; Vera, Andrés M. ; Gómez-Sicilia, Ángel ; Losada-Urzáiz, Fernando ; Uversky, Vladimir N.; Menéndez, Margarita ; Laurents, Douglas V.; Bruix, M. ; Carrión-Vázquez, Mariano Sixto
Issue Date2012
PublisherPublic Library of Science
CitationPLoS Biology 10 (2012)
AbstractAmyloidogenic neurodegenerative diseases are incurable conditions with high social impact that are typically caused by specific, largely disordered proteins. However, the underlying molecular mechanism remains elusive to established techniques. A favored hypothesis postulates that a critical conformational change in the monomer (an ideal therapeutic target) in these >neurotoxic proteins> triggers the pathogenic cascade. We use force spectroscopy and a novel methodology for unequivocal single-molecule identification to demonstrate a rich conformational polymorphism in the monomer of four representative neurotoxic proteins. This polymorphism strongly correlates with amyloidogenesis and neurotoxicity: it is absent in a fibrillization-incompetent mutant, favored by familial-disease mutations and diminished by a surprisingly promiscuous inhibitor of the critical monomeric β-conformational change, neurotoxicity, and neurodegeneration. Hence, we postulate that specific mechanostable conformers are the cause of these diseases, representing important new early-diagnostic and therapeutic targets. The demonstrated ability to inhibit the conformational heterogeneity of these proteins by a single pharmacological agent reveals common features in the monomer and suggests a common pathway to diagnose, prevent, halt, or reverse multiple neurodegenerative diseases. © 2012 Hervás et al.
Identifiersdoi: 10.1371/journal.pbio.1001335
issn: 1544-9173
Appears in Collections:(IC) Artículos
(IQFR) Artículos
Files in This Item:
File Description SizeFormat 
Carrion-Vazqiez,journal.pbio.1001335.pdf1,2 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.